In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Oxford GlycoSciences completes international follow-on

Executive Summary

Oxford GlycoSciences PLC (proteomics) has raised net proceeds of about $230.65mm through a two-part public offering: an open offer to existing shareholders (who had preemptive rights to subscribe for shares based on the size of their current holdings), followed by an oversubscirbed international offering. It total, the company placed 13.36mm shares, including the banks' overallotment.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies